Related Experiment Video
Updated: Jul 11, 2026

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma
Published on: June 10, 2017
Are we improving the long-term burden of Hodgkin's lymphoma patients with modern treatment?
Berthe M P Aleman1, Flora E van Leeuwen
1Department of Radiotherapy, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. b.aleman@nki.nl
Abstract:
The cure rate of patients who have Hodgkin's lymphoma (HL) amounts to 80% or more because of risk-adapted treatment using modern chemotherapy and radiotherapy schedules. In this article we describe important late effects after treatment of HL and how we expect the long-term burden of patients who have HL to change applying modern treatments. Because treatment always has side effects to some extent, awareness of possible late effects after treatment remains important for patients and treating physicians.
Related Concept Videos
Treatment Resistant Cancers
Treatment Resistent Cancers
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Tumor Immunotherapy